Twelve Months and Counting: Following Clinical Outcomes in Critical COVID-19 Survivors

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER THORACIC SOC
Citação
ANNALS OF THE AMERICAN THORACIC SOCIETY, v.20, n.2, p.289-295, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Rationale: Recent reports suggest that patients with severe coronavirus disease (COVID-19) often experience long-term consequences of the infection. However, studies on intensive care unit (ICU) survivors are underrepresented. Objectives: We aimed to explore 12-month clinical outcomes after critical COVID-19, describing the longitudinal progress of disabilities, frailty status, frequency of cognitive impairment, and clinical events (rehospitalization, institutionalization, and falls). Methods: We performed a prospective cohort study of survivors of COVID-19 ICU admissions in Sao Paulo, Brazil. We assessed patients every 3 months for 1 year after hospital discharge and obtained information on 15 activities of daily living (basic, instrumental, and mobility activities), frailty, cognition, and clinical events. Results: We included 428 patients (mean age of 64 yr, 61% required invasive mechanical ventilation during ICU stay). The number of disabilities peaked at 3 months compared with the pre-COVID-19 period (mean difference, 2.46; 99% confidence interval, 1.94-2.99) and then decreased at 12 months (mean difference, 0.67; 99% confidence interval, 0.28-1.07). At 12-month follow-up, 12% of patients were frail, but half of them presented frailty only after COVID-19. The prevalence of cognitive symptoms was 17% at 3 months and progressively decreased to 12.1% (P = 0.012 for trend) at the end of 1 year. Clinical events occurred in all assessments. Conclusions: Although a higher burden of disabilities and cognitive symptoms occurred 3 months after hospital discharge of critical COVID-19 survivors, a significant improvement occurred during the 1-year follow-up. However, one-third of the patients remained in worse conditions than their pre-COVID-19 status.
Palavras-chave
COVID-19, disability studies, frailty, activities of daily living
Referências
  1. Aliberti MJR, 2021, J AM GERIATR SOC, V69, P1116, DOI 10.1111/jgs.17146
  2. Apolinario D, 2016, INT J GERIATR PSYCH, V31, P4, DOI 10.1002/gps.4282
  3. Ayoubkhani D, 2022, BMJ-BRIT MED J, V377, DOI 10.1136/bmj-2021-069676
  4. Bagshaw SM, 2014, CAN MED ASSOC J, V186, pE95, DOI 10.1503/cmaj.130639
  5. Barile JP, 2012, J AMBUL CARE MANAG, V35, P292, DOI 10.1097/JAC.0b013e31826746f5
  6. Brummel NE, 2020, CRIT CARE MED, V48, P1419, DOI 10.1097/CCM.0000000000004444
  7. Brummel NE, 2017, AM J RESP CRIT CARE, V196, P64, DOI 10.1164/rccm.201605-0939OC
  8. Crook H, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1648
  9. Evans RA, 2022, LANCET RESP MED, V10, P761, DOI 10.1016/S2213-2600(22)00127-8
  10. Ferrante LE, 2015, JAMA INTERN MED, V175, P523, DOI 10.1001/jamainternmed.2014.7889
  11. Ferreira JC, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-021-00882-w
  12. Flaatten H, 2017, INTENS CARE MED, V43, P1820, DOI 10.1007/s00134-017-4940-8
  13. Fortes SQ, 2016, AGE AGEING, V45, P711, DOI 10.1093/ageing/afw084
  14. Frenkel WJ, 2014, J AM GERIATR SOC, V62, P342, DOI 10.1111/jgs.12635
  15. Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a
  16. Heesakkers H, 2022, JAMA-J AM MED ASSOC, V327, P559, DOI 10.1001/jama.2022.0040
  17. Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802
  18. Hodgson CL, 2022, AM J RESP CRIT CARE, V205, P1159, DOI 10.1164/rccm.202110-2335OC
  19. Huang LX, 2022, LANCET RESP MED, V10, P863, DOI 10.1016/S2213-2600(22)00126-6
  20. Huang LX, 2021, LANCET, V398, P747, DOI 10.1016/S0140-6736(21)01755-4
  21. Latronico N, 2022, THORAX, V77, P300, DOI 10.1136/thoraxjnl-2021-218064
  22. Liu TT, 2022, CLIN INFECT DIS, V74, P1953, DOI 10.1093/cid/ciab703
  23. Loeys T, 2012, BRIT J MATH STAT PSY, V65, P163, DOI 10.1111/j.2044-8317.2011.02031.x
  24. Lyu W, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0792-8
  25. Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6
  26. Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5
  27. Muscedere J, 2017, INTENS CARE MED, V43, P1105, DOI 10.1007/s00134-017-4867-0
  28. Mwalili SM, 2008, STAT METHODS MED RES, V17, P123, DOI 10.1177/0962280206071840
  29. National Institute for Health and Care Excellence, 2020, COVID 19 RAP GUID CR
  30. Preisser JS, 2012, CARIES RES, V46, P413, DOI 10.1159/000338992
  31. Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051
  32. Rockwood K, 2020, CAN GERIATR J, V23, P254, DOI 10.5770/cgj.23.463
  33. Tan E, 2021, CHEST, V159, P524, DOI 10.1016/j.chest.2020.10.014
  34. Taniguchi Leandro Utino, 2022, Crit Care Explor, V4, pe0712, DOI 10.1097/CCE.0000000000000712
  35. Taniguchi LU, 2022, CRIT CARE MED, V50, P955, DOI 10.1097/CCM.0000000000005488
  36. Taniguchi LU, 2020, J CRIT CARE, V59, P143, DOI 10.1016/j.jcrc.2020.06.007
  37. Thiolliere F, 2022, CRIT CARE, V26, DOI 10.1186/s13054-022-03958-6
  38. Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751